Serum gamma-glutamyltransferase and the burden of atherosclerosis in patients with acute coronary syndrome

Turk Kardiyoloji Dernegi Arsivi

Volumn 41, Issue 4, 2013, Pages 275-281

  Duran, Mustafa ^a   Uysal, Onur Kadir ^a   Yilmaz, Yücel ^a   Günebakmaz, Özgür ^b   Arinç, Hüseyin ^a   Topsakal, Ramazan ^c   Eryol, Namik Kemal ^c   Ergin, Ali ^c   Oǧuzhan, Abdurrahman ^c   Kaya, Mehmet Güngör ^c  

^a Department of Cardiology Kayseri Training and Research Hospital ^*  (Turkey)

^b HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acute coronary syndrome; Atherosclerosis; Biological markers blood; Coronary artery disease; Gamma glutamyltransferase blood; Hypertension blood; Multi variate analysis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CALORIC VESTIBULAR TEST; CARDIOVASCULAR RISK; DIABETES MELLITUS; ENZYME BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; UNSTABLE ANGINA PECTORIS; ACUTE CORONARY SYNDROME; AGED; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; ENZYMOLOGY; EVALUATION STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84879261044     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2013.99896     Document Type: Article

References (29)

1. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;109:486-91.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
3. Goldberg RJ, Glatfelter K, Burbank-Schmidt E, Lessard D, Gore JM. Trends in community mortality due to coronary heart disease. Am Heart J 2006;151:501-7. (Pubitemid 43144757)
4. Duran M, Kalay N, Akpek M, Orscelik O, Elcik D, Ocak A, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 2012;63:448-52.
5. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-8. (Pubitemid 40923403)
6. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802-7. (Pubitemid 32929115)
7. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
8. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
9. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004;109:1440. (Pubitemid 38387833)
10. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-66. (Pubitemid 36900623)
11. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31:1851-5. (Pubitemid 30620462)
12. Huang G, Zhao JL, Du H, Lan XB, Yin YH. Coronary score adds prognostic information for patients with acute coronary syndrome. Circ J 2010;74:490-5.
13. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. (Pubitemid 13187192)
14. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, et al. Assessment of the SYNTAX score in the Syntax study. Eurointervention 2009;5:50-6.
15. Aksakal E, Tanboga IH, Kurt M, Kaygin MA, Kaya A, Isik T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis 2012;221:596-601.
16. Açikel M, Sunay S, Koplay M, Gündoǧdu F, Karakelleoǧlu S. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg 2009;9:273-9.
17. Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, et al. The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009;32:220-5.
18. Whitfield JB. Serum gamma-glutamyltransferase and risk of disease. Clin Chem 2007;53:1-2.
19. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-33. (Pubitemid 46360389)
20. Breitling LP, Grandi NC, Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010;210:649-55.
21. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-80. (Pubitemid 41475797)
22. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9. (Pubitemid 38697087)
23. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355. (Pubitemid 32826505)
24. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999;47:151-60. (Pubitemid 129541449)
25. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74. (Pubitemid 36019640)
26. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-30.
27. Onat A, Can G, Örnek E, Çiçek G, Ayhan E, Doǧan Y. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity (Silver Spring) 2012;20:842-8.
28. Bozbaş H, Yildirir A, Karaçaǧlar E, Demir O, Ulus T, Eroǧlu S, et al. Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2011;39:122-8.
29. Nikkari ST, Koivu TA, Kalela A, Strid N, Sundvall J, Poikolainen K, et al. Association of carbohydrate-deficient transferrin (CDT) and gamma-glutamyl-transferase (GGT) with serum lipid profile in the Finnish population. Atherosclerosis 2001;154:485-92. (Pubitemid 32146623)